Topic

Cosmos Health

Technology & Infrastructure · Applications & agents

Cosmos Health Files AI-Driven Patent for Multiple Sclerosis Treatment

Cosmos Health Inc. (NASDAQ: COSM) has filed a patent application for a potential treatment for multiple sclerosis (MS), leveraging its AI-powered Cloudscreen drug repurposing platform. This move marks a significant advancement in the company’s

6 Feb 2025 · 1 min read

Cosmos Health

Cosmos Health Files AI-Driven Patent for Multiple Sclerosis Treatment

Trending today

U.S. Orders Federal Agencies to Remove DeepSeek AI Products Over National Security Concerns

Spotify Bets on AI Agents as a Growth Driver After Strong Third Quarter

Nebius Secures $3.5B Citi Facility to Expand AI Cloud Capacity

Therna Unveils AI Platform to Study RNA and Design Candidate Medicines

IBM Ventures Backs Leena AI to Scale Agentic AI for Enterprise Back Offices

Cosmos Health

Cosmos Health Files AI-Driven Patent for Multiple Sclerosis Treatment

Trending today

U.S. Orders Federal Agencies to Remove DeepSeek AI Products Over National Security Concerns

Spotify Bets on AI Agents as a Growth Driver After Strong Third Quarter

Nebius Secures $3.5B Citi Facility to Expand AI Cloud Capacity

Therna Unveils AI Platform to Study RNA and Design Candidate Medicines

IBM Ventures Backs Leena AI to Scale Agentic AI for Enterprise Back Offices

The AI economy, every weekday morning